Vague Takeover Chatter Regarding Cephalon (CEPH) - Pfizer (NYSE:PFE)

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

There is some vague chatter on Wall Street today about Cephalon (NASDAQ: CEPH) possibly being the target of a takeover. The suitors that have been mentioned in the past include Pfizer (NYSE: PFE) and in particular Takeda Pharmaceutical. Cephalon (CEPH) is trading well off of its lows for the day, but remains in negative territory. Currently the shares have shed 0.81% and are exchanging hands for $60.28. Even if an offer does not materialize, CEPH looks rather cheap at less than 8 times forward earnings and a PEG ratio of 0.83.

27% profit every 20 days?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!